1.09

2.83% 0.03

Pre-market: 1.09

Novabay Pharmaceuticals Inc (NBY)

Overview News Price History Discussions Forecast Stock Split

Novabay Pharmaceuticals Inc stock is traded at $1.09, with a volume of 47,047. It is up +2.83% in the last 24 hours and down -0.91% over the past month. NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.

Previous Close:

$1.06

Open:

$1.07

24h Volume:

47,047

Relative Volume:

0.04

Market Cap:

$137.35M

Revenue:

$4.75M

Net Income/Loss:

$-7.83M

P/E Ratio:

5.0069

EPS:

0.2177

Net Cash Flow:

$-7.24M

1W Performance:

+6.86%

1M Performance:

-0.91%

6M Performance:

+82.58%

1Y Performance:

+91.26%

1-Day Range:

$1.01

$1.09

1-Week Range:

$1.00

$1.11

52-Week Range:

$0.46

$4.44

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name

Novabay Pharmaceuticals Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

510-899-8800

Address

2000 Powell Street, Suite 1150, Emeryville, CA

Employee

Twitter

@NovaBayPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

NBY's Discussions on Twitter

Compare NBY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBY Novabay Pharmaceuticals Inc	1.09	133.57M	4.75M	-7.83M	-7.24M	0.2177
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-18-19	Initiated	Ladenburg Thalmann	Buy
Jul-06-18	Reiterated	H.C. Wainwright	Buy
Nov-15-17	Reiterated	Laidlaw	Buy
Jun-05-17	Initiated	ROTH Capital	Buy
Mar-27-17	Initiated	Laidlaw	Buy
Feb-06-17	Initiated	Rodman & Renshaw	Buy
Mar-07-16	Downgrade	Maxim Group	Buy → Hold
Dec-14-15	Reiterated	Maxim Group	Buy
Apr-30-15	Resumed	Maxim Group	Buy
Mar-06-13	Initiated	Ascendiant Capital Markets	Strong Buy
Jan-03-08	Initiated	Dawson James	Speculative Buy

View All

Novabay Pharmaceuticals Inc Stock (NBY) Latest News

Dec 04, 2025

Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser

Dec 04, 2025

Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser

Dec 04, 2025

Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga

Dec 04, 2025

Dec 03, 2025

Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser

Dec 03, 2025

Dec 02, 2025

Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser

Dec 02, 2025

Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser

Dec 02, 2025

Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser

Dec 02, 2025

Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser

Dec 02, 2025

Nov 27, 2025

How NovaBay Pharmaceuticals Inc. stock benefits from strong dollar - BỘ NỘI VỤ

Nov 27, 2025

Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025Quarterly Growth Report & Breakout Confirmation Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan

Nov 26, 2025

What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga

Nov 26, 2025

Nov 25, 2025

[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan

Nov 25, 2025

Nov 21, 2025